Press Announcements > FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death.
The U.S. Food and Drug Administration today announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death. The approach places nicotine, and the issue of addiction, at the center of the agency’s tobacco regulation efforts. The goal is to ensure that the FDA has the proper scientific and regulatory foundation to efficiently and effectively implement the Family Smoking Prevention and Tobacco Control Act. To make certain that the FDA is striking an appropriate balance between regulation and encouraging development of innovative tobacco products that may be less dangerous than cigarettes, the agency is also providing targeted relief on some timelines described in the May 2016 final rule that extended the FDA’s authority to additional tobacco products. The agency will also seek input on critical public health issues such as the role of flavors in tobacco products.
FDA、たばこ関連疾患に関する包括的な規制計画を発表
米国食品医薬品局（FDA）は本日、タバコとニコチンの規制に関する新しい包括的な計画を発表しました。これは、子供を保護し、タバコ関連疾病を大幅に減らすためのロードマップ。ニコチンと中毒問題をたばこ規制の中心に置いています。目標は、FDAが家族の喫煙防止およびたばこ規制法を効率的かつ効果的に実施するための適切な科学的および規制上の基盤を確保すること。
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm568923.htm